José Ignacio Andrés

Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future

Manuela Ariza, Hartmuth C. Kolb, Dieder Moechars et al. · Journal of Medicinal Chemistry · 2015 · 106 citations

Computed Tomography, Engineering, Pet-mri +19

Preclinical Evaluation of¹⁸F-JNJ64349311, a Novel PET Tracer for Tau Imaging

Lieven Declercq, Frederik Rombouts, Michel Koole et al. · Journal of Nuclear Medicine · 2017 · 86 citations · Full text

Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor

José M. Cid, Gary Tresadern, Juan A. Vega et al. · Journal of Medicinal Chemistry · 2012 · 84 citations · Full text

Rem Sleep State, Pharmacotherapy, Mglu2 Receptor Pams +22

Discovery of New Tetracyclic Tetrahydrofuran Derivatives as Potential Broad-Spectrum Psychotropic Agents

Javier Fernández, José Manuel Alonso Segura, José Ignacio Andrés et al. · Journal of Medicinal Chemistry · 2004 · 72 citations · Full text

Combinatorial Chemistry, Psychotropic Medication, Psychopharmacology +19

4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate

Michael A. Letavic, Brad M. Savall, Brett D. Allison et al. · Journal of Medicinal Chemistry · 2017 · 65 citations · Full text

Clinical Candidate, Pharmacotherapy, Vivo Target Engagement +16